Enzon: Reconstructing an Oncology Pipeline
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 65 (Table of Contents)
Published: 5 Nov-2005
DOI: 10.3833/pdr.v2005.i65.605 ISSN: 1756-7874
Section: General
Fulltext:
Abstract
Enzon acquired the worldwide rights excluding Nordic region to develop, manufacture and commercialize the Phase I drug (rhMBL) from Natimmune...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018